|
?:abstract
|
-
The corona virus disease (COVID-19) which has been declared a pandemic by the World Health Organization (WHO) in March 2020, is a major concern at present, with 11,635,939 cases and 539,026 deaths worldwide, as on 08 July 2020 The SARS CoV-2 infection had emerged in Wuhan, Hubei Province, China and is likely to have originated from the zoonotic coronaviruses, WHO has initiated an investigation on the zoonotic source of disease, to ascertain how the disease jumped between animals and humans Scientific community across the globe has been conducting research based on the knowledge from previous outbreaks of Severe Acute Respiratory Syndrome (SARS) in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012, caused by other corona viruses, and other similar epidemics to speed up the scientific discoveries and implement solutions There have been new revelations in this duration of six months in relation to its mode of transmission, efficacy of drugs, development of vaccines, methods of testing and the spread of disease The research for potential therapeutics as well as combination therapies are under different stages of trials involving about 5500 patients in 39 countries, as on 01 July 2020 There is no panacea for the treatment of Coronavirus disease, and the current treatment plan is largely symptomatic, which is mostly a combination of classical and compassionate therapeutics Considering the non-availability of specific therapeutics and vaccines for disease control, and with the increasing knowledge on the varying effects it generates post recovery, it is largely accepted that prevention is paramount The present review paper aims at providing a comprehensive understanding on origin, transmission, testing, prevention, therapeutics, to provide a guideline for effective planning for controlling COVID-19 spread by suppressing transmission and preventing associated illness and death
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}